Search for: "SANOFI-SYNTHELABO INC"
Results 21 - 40
of 45
Sort by Relevance
|
Sort by Date
2 Sep 2010, 10:51 am
Sanofi-Synthelabo v. [read post]
Three Strikes, You’re Out!? Apotex’s Latest Attempt to Invalidate the PLAVIX® Patent Denied by USPTO
9 Jul 2010, 3:00 am
Court of Appeals for the Federal Circuit (Sanofi-Synthelabo v. [read post]
3 Feb 2010, 2:00 am
Barr Laboratories, Inc. and Mylan Pharma (Patent Docs) (Patently-O) Omnicef (Cefdinir) – US: CAFC on whether a product-by-process claim is infringed by an identical product made by different process: Abbott Labs v Sandoz (IP Frontline) Pertussis vaccines – UK: EWHC dismisses Medeva appeal against pertussis vaccines SPCs refusal (The SPC Blog) Plavix (Clopidogrel) – Canada: Adding some obvious flexibility: Apotex Inc v Sanofi-Synthelabo Canada… [read post]
30 Nov 2009, 12:00 am
Budejovicky Budvar Narodni Podnik v Anheuser-Busch Inc (Class 46) (IPKat) EPO: Should green technology be subject to compulsory licensing? [read post]
2 Nov 2009, 1:20 pm
’s judgment for the Court in Apotex Inc. v. [read post]
29 Oct 2009, 11:11 am
Sanofi-Synthelabo, Inc. [read post]
13 May 2009, 11:44 pm
Cir. 2008); see also Sanofi-Synthelabo v. [read post]
23 Mar 2009, 7:34 am
Apotex, Inc. after the jump. [read post]
25 Jan 2009, 2:36 pm
The last big pharmaceutical industry acquisition came in August 2004, when Paris-based Sanofi-Synthelabo acquired Aventis SA of Strasburg, France, for $64.4 billion to create Sanofi Aventis SA, France's largest drugmaker. [read post]
24 Dec 2008, 3:00 pm
Apotex, Inc (Managing Intellectual Property) [read post]
20 Dec 2008, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Oleg Teterin seeks ‘tens of thousands of dollars’ for rights to use ;-) emoticon, a registered Russian trade mark (Techdirt) (RelatIP) (Ars Technica) (The IP Factor) (Out-Law) (Class 46) New UK copyright consultation: consultation issues include access to works, incentivising investment and creativity, recognising… [read post]
19 Dec 2008, 1:00 pm
$16.8 million for Alphapharm and Mylan: Takeda v Mylan (Patent Baristas) (Patent Docs) Boniva (Ibandronic acid) – US: Apotex challenges validity of Hoffmann-La Roche’s Boniva patent (Law360) Boniva (Ibandronic acid) – US: Orchid Chemicals & Pharmaceuticals and Orgenus Pharma seek declaratory judgment of invalidity and noninfringement in patent infringement suit brought by Hoffmann-La Roche over Boniva (Law360) Cardizem (Diltiazem) – Antitrust,… [read post]
16 Dec 2008, 5:16 am
Sanofi-Synthelabo, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively, Sanofi) brought suit under 35 U.S.C. [read post]
15 Dec 2008, 5:34 am
Sanofi-Synthelabo v. [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
14 Nov 2008, 2:08 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Plavix (Clopidogrel) - Canada: Selection patents upheld by Supreme Court: Apotex v Sanofi-Synthelabo Canada (Jeremy de Beer) (ipblog.ca)… [read post]
7 Nov 2008, 8:35 am
Sanofi-Synthelabo Canada Inc. [read post]
7 Nov 2008, 4:11 am
In a 7-0 judgment on 6 Nov 08, the Canadien Supreme Court rejected a request from Apotex Inc. to invalidate Sanofi's patent for an anti-coagulant drug (Plavix) used to combat cardiovascular degeneration.Coverage by Kirk Makin in the Globe and Mail did NOT get to the heart of this court battle involving patenting of racemates vs. patenting of enantiomers:Judge Rothstein said that in case of Sanofi's anti-coagulant drug - marketed under the name, Plavix - the… [read post]
7 Nov 2008, 3:42 am
Sandoz, Inc (Patent Docs) (PATracer) Boniva (Ibandronic acid) – US: Hoffman La Roche files third patent infringement lawsuit against Orchid over generic Boniva (GenericsWeb) Carbatrol (Carbamazepine) – US: Federal Judge grants summary judgment of noninfringement to Corepharma in Carbatrol patent dispute with Shire Laboratories (Law360) Effexor (Venlafaxine) – US: Wyeth settles with fourth drug company, Anchen Pharmaceuticals, over generic Effexor (Law360)… [read post]
25 Jun 2007, 2:10 am
DISTRICT COURTSOUTHERN DISTRICT OF NEW YORKIntellectual Property
Sale of Generic Version of Plavix Blocked; Infringed Patent Not Proved Invalid or Unenforceable
Sanofi-Synthelabo v. [read post]
